Here are relevant reports on : urea-cycle-disorder-ucd-drugs-market
-
Global Multiple Myeloma Drugs Market
2008 saw almost 12 million patients diagnosed with cancer. Despite, increasing technological advancements and research the deaths due to cancer were about 8 million people in 2008. Lung cancer accounts for the highest mortality rate. There has been a significant development in technologies and drugs/vaccines with respect to breast cancer, thyroid cancer, and pancreatic cancer therefore increasing the survival rates.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Global Weight Loss Drugs, Supplements And Cosmetics Market
Individuals with high BMI have a greater risk of developing diseases such as cancer and diabetes. This holds true for both men and women; and those with BMI above 35 are at the highest risk. However, increasing awareness about obesity is encouraging consumers to seek medical assistance and consultation for weight reduction. The market for weight-loss drugs, cosmetics, and supplements is witnessing a significant growth as these do not involve strict diet or exercise regimens. Top pharmaceutical companies have thus increased R&D investments for anti-obesity drugs with minimal or no side effects.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Preimplantation Genetic Testing Market by Product & Service (Reagents, Consumables, Instruments, Software), Technology (NGS, PCR, SNP, CGH), Procedure (Screening, Diagnosis), Application (Aneuploidy, HLA Typing), Type of cycle - Global Forecast to 2030
The global preimplantation genetic testing market, valued at US$636.4 million in 2024, stood at US$690.2 million in 2025 and is projected to advance at a resilient CAGR of 10.5% from 2024 to 2030, culminating in a forecasted valuation of US$1,135.0 million by the end of the period.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Cryostat Market by Type (Closed-Cycle, Continuous-Flow, Bath, Multistage), System Component (Dewars, Transfer Tubes, Gas Flow Pumps, Temperature Controllers, High Vacuum Pumps, Microtome Blades), Cryogen, Application & Region - Global Forecast to 2027
The cryostat market is expected to grow from USD 2.2 billion in 2022 to USD 2.8 billion by 2027, at a compound annual growth rate (CAGR) of 4.9% during the forecast period.The Key Players Leica Biosystems (Germany), Cryomech Inc. (US), Amos Scientific (Australia), MEDITE (Germany), Bright Instruments (UK), Dakewe Medical (China), Jinhua YIDI Medical Appliance Co., Ltd. (China), SLEE Medical GmbH (Germany), Advanced Research Systems (US), Lake Shore Cryotronics (US), Epredia (US), SM Scientific Instruments (India), Medimeas (India), Hacker Instruments & Industries (US), Boeckeler Instruments Inc. (US), Histo-line Laboratories (Italy), Lupetec (Brazil), SciLab Co. Ltd. (France), Cryofab, Inc. (US), Precision Cryogenics (US), attocube systems AG (Germany), AMETEK Scientific Instruments (US), Mirion Technologies (Georgia), BIOBASE (Germany), and Sipcon Instrument Industries (India).
- Published: September 2022
- Price: $ 4950
- TOC Available:
-
In Vitro Fertilization Market by Product (Equipment, Reagent, Accessories), Equipment (Imaging, Incubator, Microscope, Micromanipulator), Procedure (Conventional, ICSI, donor), Cycle (Fresh, Frozen), End-user (Hospital, Clinic) - Global Forecast to 2029
The global in vitro fertilization market, valued at US$857 million in 2023, stood at US$949 million in 2024 and is projected to advance at a resilient CAGR of 11.7% from 2024 to 2029, culminating in a forecasted valuation of US$1,650 million by the end of the period. Key drivers include rising infertility rates, advanced median age of women in childbearing years, increased funding and research activities, and improved techniques in IVF treatments globally.
- Published: August 2024
- Price: $ 4950
- TOC Available:
-
Medical Robots Transforming Healthcare – Pricing & Cost-Benefit Assessment (Price Variation (by Product (Surgical Robots, Rehabilitation Robotics, Stereotactic Radiosurgery), by Application, by Geography), Reimbursement, Selection Criteria, Buying Cycle
Medical robots are devices that are used to improve the quality of care for patients. The major types of medical robots are surgical robots, hospital and pharmacy robots, rehabilitation robots, and non-invasive radiosurgery robots. Each type of robots vary widely in prices, offer varied benefits & cost-saving advantages, and are subject to different reimbursement structures, buying cycle, price wars, and other factors.
- Published: April 2016
- Price: $ 4950
- TOC Available:
-
Ocean Thermal Energy Conversion Market by Technology (Closed Cycle, Open Cycle, Hybrid Cycle) by Location (Land Based,Shelf Based, Floating) by Application (Power Generation, Desalination , Others) by Region (North America, Asia Pacific, Europe, and Rest of the World) - Trends and Forecasts to 2030
Oceans are the world’s largest solar-energy collector and energy-storage system since they cover more than 70% of the earth’s surface. The ocean's upper layers absorb the sun's irradiation and store it as thermal energy. Ocean thermal energy conversion (OTEC) utilizes the temperature difference between the upper and the lower surface of waters to generate power in a conventional heat engine. For vertical distances of as low as 90 meters, can record temperature differences of as high as 50°C. The temperature difference between the colder deepsea layers (at 800 to 1 000 meters depth) and the warm surface is converted through a thermal cycle into electricity, heat, or cold in a heat cycle. These conversion cycles function if a temperature difference of 20°C is maintained. Since deep sea water temperature is constant at 4°C at 1 000 meters depth, the surface water temperature must be around 25 °C for OTEC to occur. One of the main drivers of the OTEC is the ability to produce non-intermittent electricity along with providing cooling without electricity consumption. Although OTEC plants exhibit a very low Carnot cycle efficiency (7%), they offer a capacity factor of 90%-95%, one of the highest amongst all power generation technologies. OTEC has the most significant potential compared to other ocean energy technologies standing at 44,000 TWh per year of steady-state power. Favorable OTEC conditions are present in the tropical belt between 30 degrees north and 30 degrees south latitudes. This technology is the most economically viable for remote island states and island countries in tropical seas. OTEC can be coupled with seawater air conditioning (SWAC) to provide cooling and seawater reverse osmosis (SWRO) to produce fresh water, and the wastewater of the electricity generation can be repurposed for aquaculture use.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Antipsychotic Drugs Market by Therapeutic Class (First Generation, Second Generation, Third Generation), Drug (Aripiprazole, Brexipiprazole, Risperidone), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) - Global Forecast to 2027
The global antipsychotic drugs market is projected to reach USD ~25 billion by 2027 from USD 14 billion in 2022, at a CAGR of 8% between 2022 and 2027.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Poultry Medicine/Pharmaceuticals Market by Animal Type (Chickens, Turkeys, Ducks), Product (Drugs, Vaccines, Feed Additives), Disease Indication (Newcastle disease, Infectious Bursal Disease, Salmonella), Route of Administration - Global Forecast to 2029
The global poultry medicine/pharmaceuticals market, valued at US$4.73 billion in 2023, stood at US$5.01 billion in 2024 and is projected to advance at a resilient CAGR of 5.9% from 2024 to 2029, culminating in a forecasted valuation of US$6.68 billion by the end of the period. The growth of the poultry medicine/pharmaceutical industry can be attributed to the rising global population and consumption of poultry meat and eggs leading to more poultry farming practiced notably in the developing regions where poultry is the cheapest source of protein.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
North America Human Microbiome Market By Drug & Supplement (Drugs, Probiotics, Prebiotics), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Diseases), Type (BCT/FMT, LBP), End User (Hospitals, Clinics, Long-term Care) - Forecast to 2031
North America Human Microbiome market, valued at US$0.43 billion in 2024, stood at US$0.78 billion in 2025 and is projected to advance at a resilient CAGR of 32.2% from 2025 to 2031, culminating in a forecasted valuation of US$4.15 billion by the end of the period. New startups in the US and Canada are driving innovation across microbiome therapeutics and diagnostics.
- Published: December 2025
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
